Prediction of functional recovery after revascularization in patients with chronic ischaemic left ventricular dysfunction: Head-to-head comparison between 99mTc-sestamibi/18F-FDG DISA SPECT and 13N-ammonia/18F-FDG PET

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 33, Issue 6, 2006, Pages 716-723

  Slart, Riemer H J A ^a   Bax, Jeroen J ^b   Van Veldhuisen, Dirk J ^a   Van Der Wall, Ernst E ^b   Irwan, Roy ^a   Sluiter, Wim J ^a   Dierckx, Rudi A ^a   De Boer, Jaep ^c   Jager, Pieter L ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c Diaconessenhuis Meppel ^*  (Netherlands)

Author keywords

DISA SPECT; LV dysfunction; Myocardial viability; PET

Indexed keywords

AMMONIA N 13; FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CONVALESCENCE; DUAL ISOTOPE SIMULTANEOUS ACQUISITION SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; FEMALE; HEART DISEASE; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE; HEART MUSCLE ISCHEMIA; HEART MUSCLE REVASCULARIZATION; HEART VENTRICLE REMODELING; HUMAN; INTERMETHOD COMPARISON; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PREDICTION; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

AGED; AMMONIUM CHLORIDE; CORONARY ARTERIOSCLEROSIS; CORONARY ARTERY BYPASS; CORONARY ARTERY DISEASE; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; NITROGEN RADIOISOTOPES; POSITRON-EMISSION TOMOGRAPHY; PROGNOSIS; RADIOPHARMACEUTICALS; RECOVERY OF FUNCTION; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TECHNETIUM TC 99M SESTAMIBI; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT;

EID: 33744909863     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-005-0016-z     Document Type: Article

References (31)

1. Tillisch J, Brunken R, Marshall R, Schwaiger M, Mandelkern M, Phelps M, et al. Reversibility of cardiac wall-motion abnormalities predicted by positron tomography. N Engl J Med 1986;314:884-8
2. Tamaki N, Kawamoto M, Tadamura E, Magata Y, Yonekura Y, Nohara R, et al. Prediction of reversible ischemia after revascularization. Perfusion and metabolic studies with positron emission tomography. Circulation 1995;91:1697-1705
3. Rizzello V, Poldermans D, Bax JJ. Assessment of myocardial viability in chronic ischemic heart disease: current status. Q J Nucl Med Mol Imaging 2005;49:81-96
4. 99mTc-tetrofosmin-FDG collimated SPECT. J Nucl Med 2000;41:1318-23
5. Sandler MP, Videlefsky S, Delbeke D, Patton JA, Meyerowitz C, Martin WH, et al. Evaluation of myocardial ischemia using a rest metabolism/stress perfusion protocol with fluorine-18 deoxyglucose/technetium-99m MIBI and dual-isotope simultaneous-acquisition single-photon emission computed tomography. J Am Coll Cardiol 1995;26:870-8
6. Knuuti MJ, Yki-Jarvinen H, Voipio-Pulkki LM, Maki M, Ruotsalainen U, Harkonen R, et al. Enhancement of myocardial [fluorine-18]fluorodeoxyglucose uptake by a nicotinic acid derivative. J Nucl Med 1994;35:989-98
7. 18F-FDG SPECT using acipimox for the assessment of myocardial viability. J Nucl Med 2003;44:877-83
8. 99mTc-sestamibi single photon emission computed tomography for the assessment of myocardial viability. Nucl Med Commun 2003;24:251-7
9. Hendel RC, Corbett JR, Cullom SJ, DePuey EG, Garcia EV, Bateman TM. The value and practice of attenuation correction for myocardial perfusion SPECT imaging: a joint position statement from the American Society of Nuclear Cardiology and the Society of Nuclear Medicine. J Nucl Cardiol 2002;9:135-43
10. Ficaro EP, Kritzman JN, Corbett JR. Development and clinical validation of normal Tc-99m sestamibi database: comparison of 3D-MSPECT to Cequal [abstract]. J Nucl Med 1999;40 (suppl):125P
11. Metz CE. Basic principles of ROC analysis. Semin Nucl Med 1978;8:283-98
12. van der Geest RJ, Buller VG, Jansen E, Lamb HJ, Baur LH, van der Wall EE, et al. Comparison between manual and semiautomated analysis of left ventricular volume parameters from short-axis MR images. J Comput Assist Tomogr 1997;21:756-65
13. 99mTc-sestamibi myocardial perfusion scintigraphy: the impact of 1 year s experience. Eur J Nucl Med Mol Imaging 2003;30:1505-9
14. Slart RH, Bax JJ, Sluiter WJ, van Veldhuisen DJ, Jager PL. Added value of attenuation-corrected Tc-99m tetrofosmin SPECT for the detection of myocardial viability: comparison with FDG SPECT. J Nucl Cardiol 2004;11:689-96
15. Van Lingen A, Huijgens PC, Visser FC, Ossenkoppele GJ, Hoekstra OS, Martens HJ, et al. Performance characteristics of a 511-keV collimator for imaging positron emitters with a standard gamma-camera. Eur J Nucl Med 1992;19:315-21
16. Bax JJ, Visser FC, Blanksma PK, Veening MA, Tan ES, Willemsen TM, et al. Comparison of myocardial uptake of fluorine-18-fluorodeoxyglucose imaged with PET and SPECT in dyssynergic myocardium. J Nucl Med 1996;37:1631-6
17. Burt RW, Perkins OW, Oppenheim BE, Schauwecker DS, Stein L, Wellman HN, et al. Direct comparison of fluorine-18-FDG SPECT, fluorine-18-FDG PET and rest thallium-201 SPECT for detection of myocardial viability. J Nucl Med 1995;36:176-9
18. Chen EQ, MacIntyre WJ, Go RT, Brunken RC, Saha GB, Wong CY, et al. Myocardial viability studies using fluorine-18-FDG SPECT: a comparison with fluorine-18-FDG PET. J Nucl Med 1997;38:582-6
19. Martin WH, Delbeke D, Patton JA, Hendrix B, Weinfeld Z, Ohana I, et al. FDG-SPECT: correlation with FDG-PET. J Nucl Med 1995;36:988-95
20. 18F]fluorodeoxyglucose single photon emission computed tomography: can it replace PET and thallium SPECT for the assessment of myocardial viability? Circulation 1998;97:843-50
21. Bax JJ, Patton JA, Poldermans D, Elhendy A, Sandler MP. 18-Fluorodeoxyglucose imaging with positron emission tomography and single photon emission computed tomography: cardiac applications. Semin Nucl Med 2000;30:281-98
22. Bax JJ, Cornel JH, Visser FC, Fioretti PM, Van Lingen A, Reijs AE, et al. Prediction of recovery of myocardial dysfunction after revascularization. Comparison of fluorine-18 fluorodeoxyglucose/thallium-201 SPECT, thallium-201 stress-reinjection SPECT and dobutamine echocardiography. J Am Coll Cardiol 1996;28:558-64
23. Bax JJ, Cornel JH, Visser FC, Fioretti PM, Van Lingen A, Huitink JM, et al. Prediction of improvement of contractile function in patients with ischemic ventricular dysfunction after revascularization by fluorine-18 fluorodeoxyglucose single-photon emission computed tomography. J Am Coll Cardiol 1997;30:377-83
24. Bax JJ, Cornel JH, Visser FC, Fioretti PM, Huitink JM, Van Lingen A, et al. F18-fluorodeoxyglucose single-photon emission computed tomography predicts functional outcome of dyssynergic myocardium after surgical revascularization. J Nucl Cardiol 1997;4:302-8
25. 18F-fluorodeoxyglucose single-photon emission computed tomography vs low-dose dobutamine echocardiography. Eur Heart J 1997;18:941-8
26. Meluzin J, Cerny J, Frelich M, Stetka F, Spinarova L, Popelova J, et al. Prognostic value of the amount of dysfunctional but viable myocardium in revascularized patients with coronary artery disease and left ventricular dysfunction. Investigators of this Multicenter Study. J Am Coll Cardiol 1998;32:912-20
27. White HD, Norris RM, Brown MA, Brandt PW, Whitlock RM, Wild CJ. Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction. Circulation 1987;76:44-51
28. Beanlands RS, Ruddy TD, deKemp RA, Iwanochko RM, Coates G, Freeman M, et al. Positron emission tomography and recovery following revascularization (PARR-1): the importance of scar and the development of a prediction rule for the degree of recovery of left ventricular function. J Am Coll Cardiol 2002;40:1735-43
29. Bax JJ, Schinkel AF, Boersma E, Elhendy A, Rizzello V, Maat A, et al. Extensive left ventricular remodeling does not allow viable myocardium to improve in left ventricular ejection fraction after revascularization and is associated with worse long-term prognosis. Circulation 2004;110:II18-22
30. Mule JD, Bax JJ, Zingone B, Martinelli F, Burelli C, Stefania A, et al. The beneficial effect of revascularization on jeopardized myocardium: reverse remodeling and improved long-term prognosis. Eur J Cardiothorac Surg 2002;22:426-30.
31. Bax JJ, Visser FC, Poldermans D, Elhendy A, Cornel JH, Boersma E, et al. Time course of functional recovery of stunned and hibernating segments after surgical revascularization. Circulation 2001;104:I314-8